Runx2/Smad3 complex negatively regulates TGF-β-induced connective tissue growth factor gene expression in vascular smooth muscle cells

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 1, 2012, Pages 23-35

  Ohyama, Yoshiaki ^a   Tanaka, Toru ^a   Shimizu, Takehisa ^a   Matsui, Hiroki ^a   Sato, Hiroko ^a   Koitabashi, Norimichi ^a   Doi, Hiroshi ^a   Iso, Tatsuya ^a   Arai, Masashi ^a   Kurabayashi, Masahiko ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Differentiation; Signaling; Smooth muscle cell

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; SMAD3 PROTEIN; SMAD4 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA;

AORTA MEDIA; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHROMATIN IMMUNOPRECIPITATION; CONNECTIVE TISSUE GROWTH FACTOR; CORE BINDING FACTOR ALPHA 1 SUBUNIT; COS CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOENZYME TECHNIQUES; LUCIFERASES; MICE; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84863070457     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.9753     Document Type: Article

References (55)

1. Bobik A: Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol, 2006; 26: 1712-1720
2. Cipollone F, Fazia M, Mincione G, Iezzi A, Pini B, Cuccurullo C, Ucchino S, Spigonardo F, Di Nisio M, Cuccurullo F, Mezzetti A, Porreca E: Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. Stroke, 2004; 35: 2253-2257
3. Bradham DM, Igarashi A, Potter RL, Grotendorst GR: Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol, 1991; 114: 1285-1294
4. Oemar BS, Luscher TF: Connective tissue growth factor. Friend or foe? Arterioscler Thromb Vasc Biol 1997; 17: 1483-1489
5. Shimo T, Nakanishi T, Kimura Y, Nishida T, Ishizeki K, Matsumura T, Takigawa M: Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. J Biochem, 1998; 124: 130-140
6. Massague J: TGF-beta signal transduction. Annu Rev Biochem, 1998; 67: 753-791
7. Miyazono K: TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev, 2000; 11: 15-22
8. ten Dijke P, Miyazono K, Heldin CH: Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem Sci, 2000; 25: 64-70
9. Miyazono K: Positive and negative regulation of TGFbeta signaling. J Cell Sci, 2000; 113 (Pt 7): 1101-1109
10. Wotton D, Lo RS, Lee S, Massague J: A Smad transcriptional corepressor. Cell, 1999; 97: 29-39
11. Akiyoshi S, Inoue H, Hanai J, Kusanagi K, Nemoto N, Miyazono K, Kawabata M: c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J Biol Chem, 1999; 274: 35269-35277
12. Luo K, Stroschein SL, Wang W, Chen D, Martens E, Zhou S, Zhou Q: The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev, 1999; 13: 2196-2206
13. Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K: Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science, 1999; 286: 771-774
14. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 1997; 89: 755-764
15. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G: Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell, 1997; 89: 747-754
16. Nishimura R, Hata K, Harris SE, Ikeda F, Yoneda T: Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone, 2002; 31: 303-312
17. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell, 1997; 89: 765-771
18. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR: Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell, 1997; 89: 773-779
19. Tanaka T, Sato H, Doi H, Yoshida CA, Shimizu T, Matsui H, Yamazaki M, Akiyama H, Kawai-Kowase K, Iso T, Komori T, Arai M, Kurabayashi M: Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells. Mol Cell Biol, 2008; 28: 1147-1160
20. Kawabata M, Inoue H, Hanyu A, Imamura T, Miyazono K: Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J, 1998; 17: 4056-4065
21. Jonk LJ, Itoh S, Heldin CH, ten Dijke P, Kruijer W: Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem, 1998; 273: 21145-21152
22. Tanaka T, Nishimura D, Wu RC, Amano M, Iso T, Kedes L, Nishida H, Kaibuchi K, Hamamori Y: Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase. J Biol Chem, 2006; 281: 15320-15329
23. Doi H, Iso T, Sato H, Yamazaki M, Matsui H, Tanaka T, Manabe I, Arai M, Nagai R, Kurabayashi M: Jagged1-selective notch signaling induces smooth muscle differentiation via a RBP-Jkappa-dependent pathway. J Biol Chem, 2006; 281: 28555-28564
24. Derynck R, Zhang Y, Feng XH: Smads: transcriptional activators of TGF-beta responses. Cell, 1998; 95: 737-740
25. Massague J, Blain SW, Lo RS: TGFbeta signaling in growth control, cancer, and heritable disorders. Cell, 2000; 103: 295-309
26. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R: TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J, 2001; 20: 2254-2272
27. Zhang YW, Yasui N, Ito K, Huang G, Fujii M, Hanai J, Nogami H, Ochi T, Miyazono K, Ito Y: A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A, 2000; 97: 10549-10554
28. Westendorf JJ, Zaidi SK, Cascino JE, Kahler R, van Wijnen AJ, Lian JB, Yoshida M, Stein GS, Li X: Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21 (CIP1/WAF1) promoter. Mol Cell Biol, 2002; 22: 7982-7992
29. Schroeder TM, Kahler RA, Li X, Westendorf JJ: Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. J Biol Chem, 2004; 279: 41998-42007
30. Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E, McAnally J, Pomajzl C, Shelton JM, Richardson JA, Karsenty G, Olson EN: Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell, 2004; 119: 555-566
31. Westendorf JJ: Transcriptional co-repressors of Runx2. J Cell Biochem, 2006; 98: 54-64
32. Vander Zwan CJ, Wheeler JC, Li LH, Tracey WD, Gergen JP: A DNA-binding-independent pathway of repression by the Drosophila Runt protein. Blood Cells Mol Dis, 2003; 30: 207-222
33. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC: Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol, 2000; 20: 8783-8792
34. Zaidi SK, Sullivan AJ, van Wijnen AJ, Stein JL, Stein GS, Lian JB: Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proceedings of the National Academy of Sciences of the United States of America, 2002; 99: 8048-8053
35. Afzal F, Pratap J, Ito K, Ito Y, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Javed A: Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J Cell Physiol, 2005; 204: 63-72
36. Selvamurugan N, Kwok S, Partridge NC: Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells. J Biol Chem, 2004; 279: 27764-27773
37. Kang JS, Alliston T, Delston R, Derynck R: Repression of Runx2 function by TGF-beta through recruitment of class β histone deacetylases by Smad3. Embo Journal, 2005; 24: 2543-2555
38. Yamaai T, Nakanishi T, Asano M, Nawachi K, Yoshimichi G, Ohyama K, Komori T, Sugimoto T, Takigawa M: Gene expression of connective tissue growth factor (CTGF/CCN2) in calcifying tissues of normal and cbfa1-null mutant mice in late stage of embryonic development. J Bone Miner Metab, 2005; 23: 280-288
39. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A: CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int, 2002; 62: 1149-1159
40. Reguly T, Wrana JL: In or out? The dynamics of Smad nucleocytoplasmic shuttling. Trends Cell Biol, 2003; 13: 216-220
41. Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M, Lavery C, Margetts PJ, Roberts AB, Gauldie J: Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol, 2004; 173: 2099-2108
42. Tran CM, Markova D, Smith HE, Susarla B, Ponnappan RK, Anderson DG, Symes A, Shapiro IM, Risbud MV: Regulation of CCN2/connective tissue growth factor expression in the nucleus pulposus of the intervertebral disc: role of Smad and activator protein 1 signaling. Arthritis Rheum, 2010; 62: 1983-1992
43. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A: CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem, 2001; 276: 10594-10601
44. Yu F, Chou CW, Chen CC: TNF-alpha suppressed TGFbeta-induced CTGF expression by switching the binding preference of p300 from Smad4 to p65. Cell Signal, 2009; 21: 867-872
45. Nowinski D, Koskela A, Kiwanuka E, Bostrom M, Gerdin B, Ivarsson M: Inhibition of connective tissue growth factor/CCN2 expression in human dermal fibroblasts by interleukin-1alpha and beta. J Cell Biochem, 2010; 110: 1226-1233
46. Fu M, Zhang J, Zhu X, Myles DE, Willson TM, Liu X, Chen YE: Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J Biol Chem, 2001; 276: 45888-45894
47. Tan X, Dagher H, Hutton CA, Bourke JE: Effects of PPAR gamma ligands on TGF-beta1-induced epithelialmesenchymal transition in alveolar epithelial cells. Respir Res, 2010; 11: 21
48. Kumar MS, Owens GK: Combinatorial control of smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol, 2003; 23: 737-747
49. Demer LL, Tintut Y: Vascular calcification: pathobiology of a multifaceted disease. Circulation, 2008; 117: 2938-2948
50. Shao JS, Cai J, Towler DA: Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol, 2006; 26: 1423-1430
51. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res, 2000; 87: E10-17
52. Nakahara T, Sato H, Shimizu T, Tanaka T, Matsui H, Kawai-Kowase K, Sato M, Iso T, Arai M, Kurabayashi M: Fibroblast growth factor-2 induces osteogenic differentiation through a Runx2 activation in vascular smooth muscle cells. Biochem Biophys Res Commun, 2010; 394: 243-248
53. Oemar BS, Werner A, Garnier JM, Do DD, Godoy N, Nauck M, Marz W, Rupp J, Pech M, Luscher TF: Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation, 1997; 95: 831-839
54. Cicha I, Yilmaz A, Klein M, Raithel D, Brigstock DR, Daniel WG, Goppelt-Struebe M, Garlichs CD: Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler Thromb Vasc Biol, 2005; 25: 1008-1013
55. Hishikawa K, Oemar BS, Tanner FC, Nakaki T, Luscher TF, Fujii T: Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem, 1999; 274: 37461-37466